Inhibition of human tumor cell growth in vitro and in vivo by a specific inhibitor of human farnesyltransferase: BIM-46068

International Journal of Cancer

Volumn 83, Issue 2, 1999, Pages 283-287

  Prevost, Grégoire P ^a   Pradines, Anne ^b   Viossat, Isabelle ^a   Brezak, Marie Christine ^a   Miquel, Karine ^b   Lonchampt, Marie Odile ^a   Kasprzyk, Philip ^c   Favre, Gilles ^b   Pignol, Bernadette ^a   Le Breton, Christine ^d   Dong, Jesse ^c   Morgan, Barry ^c  

^a Institut Henri Beaufour   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c Biomeasure Inc   (United States)

^d EXPANSIA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIM 46050; BIM 46068; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON CANCER; ENZYME INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYROID CANCER;

ALKYL AND ARYL TRANSFERASES; AMINO ACIDS, CYCLIC; ANIMALS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; FEMALE; GENES, RAS; GROWTH INHIBITORS; HUMANS; MICE; MICE, NUDE; MUTATION; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; RAS PROTEINS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0032859475     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991008)83:2<283::AID-IJC22>3.0.CO;2-6     Document Type: Article

References (20)

1. BERNHARD, E.J., KAO, G., COX, A.D., SEBTI, S.M., HAMILTON, A.D., MUSCHEL, R.J. and MCKENNA, W.G., The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts. Cancer Res., 56, 1727-1730 (1996).
2. CATES, C.A., MICHAEL, R.L., STAYROOK, K.R., HARVEY, K.A., BURKE, Y.D., RANDALL, S.K., CROWELL, P.L. and CROWELL, D.N., Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett., 110, 49-55 (1996).
3. DU, W., LEBOWITZ, P.F. and PRENDERGAST, G.C., Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol. cell. Biol., 19, 1831-1840 (1999).
4. FREIJE, J.M., LAWRENCE, J.A., HOLLINGSHEAD, M.G., DE LA ROSA, A., NARAYANAN, V., GREVER, M., SAUSVILLE, E.A., PAULL, K. and STEEG, P.S., Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines. Nature (Med.), 3, 395-401 (1997).
5. ITO, T., KAWATA, S., TAMURA, S., IGURA, T., NAGASE, T., MIYAGAWA, J.I., YAMAZAKI, E., ISHIGURO, H. and MATASUZAWA, Y., Suppression of human pancreatic cancer growth in BALB/c nude mice by manumycin, a farnesyl: protein transferase inhibitor. Jpn. J. Cancer Res., 87, 113-116 (1996).
6. JAMES, G., GOLDSTEIN, J.L. and BROWN, M.S., Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells. Proc. nat. Acad. Sci. (Wash.), 93, 4454-4458 (1996).
7. JANSEN, B., WADL, H., INOUE, S.A., TRULZSCH, B., SELZER, E., DUCHENE, M., EICHLER, H.G., WOLFF, K. and PEHAMBERGER, H., Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism. Antisense Res. Dev., 5, 271-277 (1995).
8. KHAN, S.G., DUMMER, R., SIDDIQUI, J., BICKERS, D.R., AGARWAL, R. and MUKHTAR, H., Farnesyltransferase activity and mRNA expression in human skin basal cell carcinomas. Biochem. biophys. Res. Comm., 220, 795-801 (1996).
9. KITA, K., SAITO, S., MORIOKA, C.Y. and WATANABE, A., Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes. Int. J. Cancer, 80, 553-558 (1999).
10. LERNER, E.G., ZHANG, T.T., KNOWLES, D.B., QIAN, Y., HAMILTON, A.D. and SEBTI, S.M., Inhibition of the prenylation of K-Ras, but not H-or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines. Oncogene, 15, 1283-1288 (1997).
11. LI, M., LONIAL, H., CITARELLA, R., LINDH, D., COLINA, L. and KRAMER, R., Tumor inhibitory activity of anti-ras ribozymes delivered by retroviral gene transfer. Cancer Gene Ther., 3, 221-229 (1996).
12. LIU, M. and 24 OTHERS, Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res., 58, 4947-4956 (1998).
13. 2-M enrichment in A549 cells. Cancer Res., 57, 1846-1850 (1997).
14. NAGASE, T., KAWATA, S., NAKAJIMA, H., TAMURA, S., YAMASAKI, E., FUKUI, K., YAMAMOTO, K., MIYAGAWA, J., MATSUMURA, I., MATSUDA, Y. and MATSUZAWA, Y., Effect of farnesyltransferase overexpression on cell growth and transformation. Int. J. Cancer, 80, 126-133 (1999).
15. NAGASU, T., YOSHIMATSU, K., ROWELL, C., LEWIS, M.D. and GARCIA, A.M., Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. Cancer Res., 55, 5310-5314 (1995).
16. SEBTI, S. and HAMILTON, A.D., Inhibitors of prenyl transferases. Curr. Opin. Oncol., 9, 557-561 (1997).
17. SEPP-LORENZINO, L., MA, Z., RANDS, E., KOHL, N.E., GIBBS, J.B., OLIFF, A. and ROSEN, N., A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res., 55, 5302-5309 (1995).
18. SUN, J., QIAN, Y., HAMILTON, A.D. and SEBTI, S.M., Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene, 16, 1467-1473 (1998).
19. WHYTE, D.B., KIRSCHMEIER, P., HOCKENBERRY, T.N., NUNEZ-OLIVA, I., JAMES, L., CATINO, J.J., BISHOP, W.R. and PAI, J.K., K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J biol. Chem., 272, 14459-14464 (1997).
20. XU, X.Q., MCGUIRE, T.F., BLASKOVICH, M.A., SEBTI, S.M. and ROMERO, G., Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts. Arch. Biochem. Biophys., 326, 233-237 (1996).